Intro

This chapter explores the anti-obesity drug Zepbound, highlighting its active ingredient terzepatide and the complexities of naming pharmaceuticals. The discussion extends to the wider implications of anti-obesity medications on health and societal perceptions.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app